Redeye: Westpay - Fourth Consecutive Quarter with Top-line Growth
Redeye thinks Westpay’s Q1 report was slightly better than expected. Hence, we make minor changes in our estimates following the report. However, we lower our base case as we raise the risk-free rate due to higher risk-premium in the market.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/